[go: up one dir, main page]

IL160742A0 - 6,7-dihydro-5h-pyrazolo[1,2-a] pyrazol-1-ones which control inflammatory cytokines - Google Patents

6,7-dihydro-5h-pyrazolo[1,2-a] pyrazol-1-ones which control inflammatory cytokines

Info

Publication number
IL160742A0
IL160742A0 IL16074202A IL16074202A IL160742A0 IL 160742 A0 IL160742 A0 IL 160742A0 IL 16074202 A IL16074202 A IL 16074202A IL 16074202 A IL16074202 A IL 16074202A IL 160742 A0 IL160742 A0 IL 160742A0
Authority
IL
Israel
Prior art keywords
pyrazolo
pyrazol
dihydro
ones
inflammatory cytokines
Prior art date
Application number
IL16074202A
Other languages
English (en)
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of IL160742A0 publication Critical patent/IL160742A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/20Spiro-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/20Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Cardiology (AREA)
  • Communicable Diseases (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
IL16074202A 2001-09-20 2002-09-20 6,7-dihydro-5h-pyrazolo[1,2-a] pyrazol-1-ones which control inflammatory cytokines IL160742A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32362501P 2001-09-20 2001-09-20
PCT/US2002/030135 WO2003024971A1 (fr) 2001-09-20 2002-09-20 6,7-dihydro-5h-pyrazolo[1,2-a]pyrazol-1-ones controlant les cytokines inflammatoires

Publications (1)

Publication Number Publication Date
IL160742A0 true IL160742A0 (en) 2004-08-31

Family

ID=23259997

Family Applications (3)

Application Number Title Priority Date Filing Date
IL16074202A IL160742A0 (en) 2001-09-20 2002-09-20 6,7-dihydro-5h-pyrazolo[1,2-a] pyrazol-1-ones which control inflammatory cytokines
IL16068202A IL160682A0 (en) 2001-09-20 2002-09-20 Spirocyclic-6, 7-dihydro-5h-pyrazolo [1,2a] pyrazol-1-ones which control inflammatory cytokines
IL16074102A IL160741A0 (en) 2001-09-20 2002-09-20 Compounds which inhibit the release of inflammatory cytokines

Family Applications After (2)

Application Number Title Priority Date Filing Date
IL16068202A IL160682A0 (en) 2001-09-20 2002-09-20 Spirocyclic-6, 7-dihydro-5h-pyrazolo [1,2a] pyrazol-1-ones which control inflammatory cytokines
IL16074102A IL160741A0 (en) 2001-09-20 2002-09-20 Compounds which inhibit the release of inflammatory cytokines

Country Status (33)

Country Link
US (2) US6566357B1 (fr)
EP (3) EP1427728B1 (fr)
JP (3) JP2005504082A (fr)
KR (4) KR20060036125A (fr)
CN (3) CN1250551C (fr)
AR (3) AR037145A1 (fr)
AT (3) ATE287887T1 (fr)
AU (2) AU2002334641B2 (fr)
BR (3) BR0212905A (fr)
CA (3) CA2461072A1 (fr)
CO (3) CO5560589A2 (fr)
CY (1) CY1106398T1 (fr)
CZ (3) CZ2004361A3 (fr)
DE (3) DE60213108T2 (fr)
DK (2) DK1427732T3 (fr)
EG (2) EG24363A (fr)
ES (3) ES2268154T3 (fr)
HK (2) HK1071366A1 (fr)
HU (3) HUP0402378A3 (fr)
IL (3) IL160742A0 (fr)
MA (3) MA27064A1 (fr)
MX (3) MXPA04002574A (fr)
MY (2) MY129329A (fr)
NO (2) NO20041594L (fr)
NZ (3) NZ531063A (fr)
PE (3) PE20030446A1 (fr)
PL (3) PL370362A1 (fr)
PT (3) PT1427727E (fr)
RU (3) RU2272040C2 (fr)
SA (1) SA03230529B1 (fr)
SK (3) SK1502004A3 (fr)
WO (3) WO2003024971A1 (fr)
ZA (3) ZA200401260B (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6730668B2 (en) * 2001-09-20 2004-05-04 The Procter & Gamble Company 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines
US6849627B2 (en) 2001-09-20 2005-02-01 The Procter & Gamble Company 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines
US7087615B2 (en) 2001-09-20 2006-08-08 The Procter & Gamble Company 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which provide analgesia
US7473695B2 (en) * 2001-10-22 2009-01-06 Mitsubishi Tanabe Pharma Corporation 4-imidazolin-2-one compounds
US6677337B2 (en) * 2002-03-19 2004-01-13 The Procter & Gamble Company 1,2-dihydropyrazol-3-ones which controls inflammatory cytokines
EP1542680B1 (fr) * 2002-09-09 2007-03-07 Amgen Inc. Derivés de 1, 2-dihydro-pyrazol-3-one et 3-alcoxy-1h-pyrazole substitués 1, 4, 5-pour l'utilisation comme agents reduisant le tnf-alpha et l'interleukine dans le traitement des inflammations
BRPI0408444A (pt) * 2003-04-03 2006-04-04 Merck Patent Gmbh derivados de 1-n-(fenil)-2-n-(fenil) pirazolidina-1,2-dicarboxamida como inibidores de fator xa de coagulação para o tratamento de trombose
GB0308466D0 (en) * 2003-04-11 2003-05-21 Novartis Ag Organic compounds
US7482356B2 (en) * 2003-11-10 2009-01-27 The Procter & Gamble Company Bicyclic pyrazolone cytokine inhibitors
JP2009534399A (ja) * 2006-04-18 2009-09-24 アボット・ラボラトリーズ バニロイド受容体サブタイプ1型(vr1)の拮抗薬およびその使用
DE102008060549A1 (de) 2008-12-04 2010-06-10 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Wirkstoff-Peptid-Konstrukt zur extrazellulären Anreicherung
JP2012527461A (ja) * 2009-05-19 2012-11-08 ダウ アグロサイエンシィズ エルエルシー 真菌を防除するための化合物および方法
CN107636366B (zh) 2015-06-15 2021-03-12 卡明斯公司 燃烧室弹性装置
WO2017151409A1 (fr) 2016-02-29 2017-09-08 University Of Florida Research Foundation, Incorporated Méthodes de chimiothérapie
CN107033090B (zh) * 2017-05-16 2019-05-07 无锡捷化医药科技有限公司 一种1,2,3,4-四氢噌啉的制备方法
RU2721684C1 (ru) * 2019-09-06 2020-05-21 Федеральное государственное бюджетное образовательное учреждение высшего образования "Пермский государственный национальный исследовательский университет" Метил 2,3,8-триоксо-4-фенилтетрагидро-6Н-пиразоло[1,2-а]пирроло[2,3-c]пиразол-9а(1Н)-карбоксилаты
US20240425524A1 (en) * 2021-10-27 2024-12-26 Merck Sharp & Dohme Llc Spirotricycle ripk1 inhibitors and methods of uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1054291A (fr) 1963-02-26
GB1124982A (en) * 1965-02-09 1968-08-21 Lepetit Spa Diazabicyclo octanes and derivatives thereof
CH529153A (fr) 1969-10-27 1972-10-15 Lepetit Spa Procédé de préparation de pyrazolo (1,2-b) phtalazine-1,5 (10H)-diones
US5358924A (en) * 1991-03-21 1994-10-25 Bayer Aktiengesellschaft 3-hydroxy-4-aryl-5-oxo-pyrozoline derivatives, compositions and use
HU229958B1 (hu) * 1999-09-07 2015-03-30 Syngenta Participations Ag Herbicid vegyületek, ezeket tartalmazó készítmények, eljárás a vegyületek előállítására, valamint eljárás gyomnövények irtására
US6730668B2 (en) * 2001-09-20 2004-05-04 The Procter & Gamble Company 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines

Also Published As

Publication number Publication date
RU2004111803A (ru) 2005-10-10
ATE287887T1 (de) 2005-02-15
PE20030446A1 (es) 2003-07-21
MY129329A (en) 2007-03-30
HUP0402378A2 (hu) 2005-02-28
PL370351A1 (en) 2005-05-16
PT1427732E (pt) 2006-12-29
CY1106398T1 (el) 2011-10-12
EG24413A (en) 2009-05-25
US20030105084A1 (en) 2003-06-05
WO2003024973A1 (fr) 2003-03-27
BR0212905A (pt) 2004-10-13
PT1427727E (pt) 2005-06-30
PE20030430A1 (es) 2003-06-24
US6566357B1 (en) 2003-05-20
NO20041605L (no) 2004-06-21
JP2005504082A (ja) 2005-02-10
DE60213108D1 (de) 2006-08-24
WO2003024971A1 (fr) 2003-03-27
DE60202782D1 (de) 2005-03-03
RU2278864C2 (ru) 2006-06-27
MA27065A1 (fr) 2004-12-20
AU2002327690B2 (en) 2006-07-20
KR20060036125A (ko) 2006-04-27
AR037145A1 (es) 2004-10-27
BR0212673A (pt) 2004-08-24
ATE356126T1 (de) 2007-03-15
SK1502004A3 (en) 2004-09-08
AR037237A1 (es) 2004-11-03
EP1427728A1 (fr) 2004-06-16
HUP0402500A2 (hu) 2005-03-29
EP1427732B1 (fr) 2006-07-12
MY129069A (en) 2007-03-30
DE60202782T2 (de) 2006-01-19
CN1555375A (zh) 2004-12-15
PL370415A1 (en) 2005-05-30
MA27066A1 (fr) 2004-12-20
KR20040035837A (ko) 2004-04-29
NZ531122A (en) 2005-09-30
JP2005504083A (ja) 2005-02-10
ZA200401402B (en) 2004-08-27
ES2282459T3 (es) 2007-10-16
HUP0500752A2 (en) 2006-01-30
BR0212716A (pt) 2004-08-03
CN1249066C (zh) 2006-04-05
DE60218704D1 (de) 2007-04-19
MXPA04002569A (es) 2004-05-31
RU2299885C2 (ru) 2007-05-27
RU2004111805A (ru) 2005-04-10
US6821971B2 (en) 2004-11-23
ES2268154T3 (es) 2007-03-16
CN1257905C (zh) 2006-05-31
HUP0402378A3 (en) 2008-10-28
SA03230529B1 (ar) 2008-06-21
RU2272040C2 (ru) 2006-03-20
HK1071366A1 (en) 2005-07-15
CA2461072A1 (fr) 2003-03-27
ATE332901T1 (de) 2006-08-15
KR100623879B1 (ko) 2006-09-19
PE20030474A1 (es) 2003-07-22
CO5560590A2 (es) 2005-09-30
SK1482004A3 (en) 2004-08-03
CZ2004361A3 (cs) 2004-07-14
AR037502A1 (es) 2004-11-17
NZ531063A (en) 2007-08-31
DK1427728T3 (da) 2007-07-09
MA27064A1 (fr) 2004-12-20
CN1556811A (zh) 2004-12-22
CA2461071A1 (fr) 2003-03-27
NO20041594L (no) 2004-06-21
CZ2004358A3 (cs) 2004-07-14
IL160682A0 (en) 2004-08-31
EP1427727A1 (fr) 2004-06-16
MXPA04002570A (es) 2004-05-31
ZA200401403B (en) 2004-08-30
IL160741A0 (en) 2004-08-31
EP1427727B1 (fr) 2005-01-26
ZA200401260B (en) 2004-08-30
AU2002334641B2 (en) 2007-03-29
CO5560579A2 (es) 2005-09-30
SK1492004A3 (en) 2004-11-03
DE60218704T2 (de) 2007-11-08
HK1071565A1 (en) 2005-07-22
KR20040035836A (ko) 2004-04-29
EP1427728B1 (fr) 2007-03-07
JP2005504081A (ja) 2005-02-10
CN1250551C (zh) 2006-04-12
NZ531123A (en) 2006-08-31
PL370362A1 (en) 2005-05-16
EP1427732A1 (fr) 2004-06-16
MXPA04002574A (es) 2004-06-18
HUP0402500A3 (en) 2008-10-28
CO5560589A2 (es) 2005-09-30
DK1427732T3 (da) 2006-10-30
EG24363A (en) 2009-03-04
RU2004111806A (ru) 2005-03-27
ES2237691T3 (es) 2005-08-01
CN1555379A (zh) 2004-12-15
CA2461073A1 (fr) 2003-03-27
WO2003024970A1 (fr) 2003-03-27
DE60213108T2 (de) 2007-02-08
CZ2004345A3 (cs) 2004-06-16
KR100656126B1 (ko) 2006-12-12
KR20040035835A (ko) 2004-04-29
PT1427728E (pt) 2007-05-31

Similar Documents

Publication Publication Date Title
GB0221015D0 (en) Vehicle stability control
AP2003002940A0 (en) Azaindoles.
HUP0500752A2 (en) 6,7-dihydro-5h-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines
AU2002351525A1 (en) System-on-a-chip controller
AU2002233706A1 (en) Pyridopyrimidine or naphthyridine derivative
GB0102212D0 (en) Controller
MXPA03007623A (es) Derivado de piridopirimidina o naftiridina.
AU2003255323A1 (en) Imidazo`1,2-a!pyridines
EP1380924A4 (fr) Unite de commande
AUPR528001A0 (en) Firearms
GB0106099D0 (en) Carriages
AU2002329267A1 (en) Antibacterial macrocycles
AU2002343106A1 (en) Contactors
EP1439303A4 (fr) Unite de commande d'etrangleur automatique
AUPR757501A0 (en) Firearms
AU2002318478A1 (en) Zeolite ssz-59
GB2374730B (en) Control
AU2002233664A1 (en) Naphthyridine derivative
AU2002327093A1 (en) 1,2-dihydro-2-oxo-1,8-naphthyridine derivative
GB0128539D0 (en) Contactors
AU2002244935A1 (en) 8-thiazolyl(1,2,4)triazolo(1,5-c)pyrimidine derivative
GB0112658D0 (en) Control structure
AU2002246225A1 (en) Movable structure
AU2002241155A1 (en) Control arrangement
AUPR513501A0 (en) Controller